{
    "N/R/U": null,
    "Applicant": "Kite Pharma Inc.",
    "BLA Number": "125643",
    "Proprietary Name": "Yescarta",
    "Proper Name": "axicabtagene ciloleucel",
    "BLA Type": "351(a)",
    "Strength": "2 \u00d7 10^6 CAR-POSITIVE VIABLE T CELLS PER KG OF BODY WEIGHT",
    "Dosage Form": "Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Bag",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "October 18, 2017",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2064",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "April 01, 2029",
    "drug": [
        {
            "name": "axicabtagene ciloleucel",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13915"
        }
    ]
}